323 related articles for article (PubMed ID: 22072713)
1. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.
Murakami K; Murata N; Noda Y; Tahara S; Kaneko T; Kinoshita N; Hatsuta H; Murayama S; Barnham KJ; Irie K; Shirasawa T; Shimizu T
J Biol Chem; 2011 Dec; 286(52):44557-68. PubMed ID: 22072713
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of the amyloidogenic pathway by cytoplasmic superoxide radicals in an Alzheimer's disease mouse model.
Murakami K; Murata N; Noda Y; Irie K; Shirasawa T; Shimizu T
Biosci Biotechnol Biochem; 2012; 76(6):1098-103. PubMed ID: 22790929
[TBL] [Abstract][Full Text] [Related]
3. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease.
Dumont M; Wille E; Stack C; Calingasan NY; Beal MF; Lin MT
FASEB J; 2009 Aug; 23(8):2459-66. PubMed ID: 19346295
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease.
Massaad CA; Washington TM; Pautler RG; Klann E
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13576-81. PubMed ID: 19666610
[TBL] [Abstract][Full Text] [Related]
5. Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model.
Guo C; Zhang S; Li JY; Ding C; Yang ZH; Chai R; Wang X; Wang ZY
Sci Rep; 2016 Jul; 6():29396. PubMed ID: 27406855
[TBL] [Abstract][Full Text] [Related]
6. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
[TBL] [Abstract][Full Text] [Related]
7. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
8. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
Jiang H; Niu F; Zheng Y; Xu Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
[TBL] [Abstract][Full Text] [Related]
9. Brain beta-amyloid accumulation in transgenic mice expressing mutant superoxide dismutase 1.
Turner BJ; Li QX; Laughton KM; Masters CL; Lopes EC; Atkin JD; Cheema SS
Neurochem Res; 2004 Dec; 29(12):2281-6. PubMed ID: 15672551
[TBL] [Abstract][Full Text] [Related]
10. Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease?
McLimans KE; Clark BE; Plagman A; Pappas C; Klinedinst B; Anatharam V; Kanthasamy A; Willette AA
Antioxid Redox Signal; 2019 Sep; 31(8):572-578. PubMed ID: 31088292
[TBL] [Abstract][Full Text] [Related]
11. Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.
Carnevale D; Mascio G; D'Andrea I; Fardella V; Bell RD; Branchi I; Pallante F; Zlokovic B; Yan SS; Lembo G
Hypertension; 2012 Jul; 60(1):188-97. PubMed ID: 22615109
[TBL] [Abstract][Full Text] [Related]
12. Oxidative Stress during the Progression of β-Amyloid Pathology in the Neocortex of the Tg2576 Mouse Model of Alzheimer's Disease.
Porcellotti S; Fanelli F; Fracassi A; Sepe S; Cecconi F; Bernardi C; Cimini A; Cerù MP; Moreno S
Oxid Med Cell Longev; 2015; 2015():967203. PubMed ID: 25973140
[TBL] [Abstract][Full Text] [Related]
13. Presenilins promote the cellular uptake of copper and zinc and maintain copper chaperone of SOD1-dependent copper/zinc superoxide dismutase activity.
Greenough MA; Volitakis I; Li QX; Laughton K; Evin G; Ho M; Dalziel AH; Camakaris J; Bush AI
J Biol Chem; 2011 Mar; 286(11):9776-86. PubMed ID: 21239495
[TBL] [Abstract][Full Text] [Related]
14. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic superoxide radical: a possible contributing factor to intracellular Aβ oligomerization in Alzheimer disease.
Murakami K; Shimizu T
Commun Integr Biol; 2012 May; 5(3):255-8. PubMed ID: 22896786
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition.
Dumont M; Ho DJ; Calingasan NY; Xu H; Gibson G; Beal MF
Free Radic Biol Med; 2009 Oct; 47(7):1019-27. PubMed ID: 19596066
[TBL] [Abstract][Full Text] [Related]
17. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.
O'Neal-Moffitt G; Delic V; Bradshaw PC; Olcese J
Mol Neurodegener; 2015 Jul; 10():27. PubMed ID: 26159703
[TBL] [Abstract][Full Text] [Related]
20. Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD.
Kitazawa M; Cheng D; Laferla FM
J Neurochem; 2009 Mar; 108(6):1550-60. PubMed ID: 19183260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
